Fetal thrombocytopenia

Seminars in Fetal and Neonatal Medicine

Volumn 13, Issue 4, 2008, Pages 223-230

  Porcelijn, L ^a   Van den Akker, E S A ^b   Oepkes, D ^c  

^a Sanquin Diagnostiek   (Netherlands)

^b Onze Lieve Vrouwe Gasthuis ^*  (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Fetus; FNAIT; Human platelet antigens; Intracranial hemorrhage; Thrombocytopenia

Indexed keywords

ALLOANTIBODY; DEXAMETHASONE; ERYTHROCYTE ANTIGEN; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN; MATERNAL ANTIBODY; PREDNISONE;

ARTICLE; BRAIN HEMORRHAGE; CHILDBIRTH; DEATH; DISABILITY; DISEASE SEVERITY; FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; FETUS DISEASE; HUMAN; NONHUMAN; PLACENTA; PREGNANCY; SKIN BLEEDING; SYMPTOMATOLOGY; THROMBOCYTE; THROMBOCYTE DYSFUNCTION; THROMBOCYTOPENIA;

ANTIGENS, HUMAN PLATELET; AUTOANTIBODIES; BLOOD PLATELETS; DELIVERY, OBSTETRIC; FEMALE; FETAL DISEASES; GENOTYPE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INCIDENCE; PARVOVIRIDAE INFECTIONS; PREGNANCY; RH-HR BLOOD-GROUP SYSTEM; THROMBOCYTOPENIA;

EID: 44649084847     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2008.02.008     Document Type: Article

References (39)

1. Murray N.A., and Roberts I.A. Circulating megakaryocytes and their progenitors in early thrombocytopenia in preterm neonates. Pediatr Res 40 (1996) 112-119
2. Williamson I.M., Hackett G.A., Rennie J.M., et al. The natural history of fetomaternal alloimmunisation to the platelet-specific antigen HPA-1a (PLA1, Zwa) as determined by antenatal screening. Blood 92 (1995) 2280-2287
3. Davoren A., McParland P., Crowley J., et al. Antenatal screening for human platelet antigen-1a: results of a prospective study at a large maternity hospital in Ireland. Br J Obstet Gynaecol 110 (2003) 492-496
4. Newman P.J., Derbes R.S., and Aster R.H. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 83 (1989) 1778-1781
5. Mueller-Eckhardt C., Kiefel V., Grubert A., et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1 (1989) 363-366
6. Davoren A., Curtis B.R., Aster R.H., et al. Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia. Transfusion 44 (2004) 1220-1225
7. Rudensky A.Y., Preston-Hurlburt P., Hong S.C., et al. Sequence analysis of peptide bound to MHC class II molecules. Nature 353 (1991) 622-627
8. L'Abbé D., Tremblay L., Goldman M., et al. Alloimmunisation to platelet antigen HPA-1a (Zwa) association with HLA-DRw52a is not 100%. Transfus Med 2 (1992) 251
9. Turner M.L., Bessos H., Fagge T., et al. Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a. Transfusion 45 (2005) 1945-1956
10. Blanchette V.S., Chen L., de Friedberg Z.S., et al. Alloimmunisation to the PlA1 platelet antigen: results of a prospective study. Br J Haematol 74 (1990) 209-215
11. Bussel J.B., Berkowitz R.L., Lynch L., et al. Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin: a randomized trial of the addition of low-dose steroid to intravenous gamma-globulin. Am J Obstet Gynecol 174 (1996) 1414-1423
12. Spencer J.A., and Burrows R.F. Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis. Aust N Z J Obstet Gynaecol 41 (2001) 45-55
13. Bussel J.B., Richard M.D., Berkowitz L., et al. Antenatal treatment of neonatal alloimmune thrombocytopenia. N Engl J Med 319 (1988) 1374-1378
14. Bussel J.B., Zabusky M.R., Berkowitz R.L., et al. Fetal alloimmune thrombocytopenia. N Engl J Med 337 (1997) 22-24
15. Murphy M.F., Metcalfe P., Waters A.H., et al. Antenatal management of severe feto-maternal alloimmune thrombocytopenia: HLA incompatibility may affect responses to fetal platelet transfusions. Blood 81 (1993) 2174-2179
16. de Vries L.S., Connell J., Bydder G.M., et al. Recurrent intracranial haemorrhages in utero in an infant with alloimmune thrombocytopenia. Case report. Br J Obstet Gynaecol 95 (1988) 299-302
17. Kaplan C., Porcelijn L., Vanlieferinghen P., et al. Anti-HPA-9bw (Maxa) fetomaternal alloimmunisation, a clinically severe neonatal thrombocytopenia: difficulties in diagnosis and therapy and report on eight families. Transfusion 45 (2005) 1799-1803
18. Kiefel V., Santoso S., and Weisheit M. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet reactive antibodies. Blood 70 (1987) 1722-1726
19. Lucas G.F., and Rogers S.E. Evaluation of an enzyme-linked immunosorbent assay kit (GTI PakPlus) for the detection of antibodies against human platelet antigens. Transfus Med 9 (1999) 63-67
20. van der Schoot C.E., Tax G.H.M., Rijnders R.J.P., de Haas M., and Christiaens G.C.M.L. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed. Transfus Med Rev 17 (2003) 31-44
21. Bertrand C., Martageix C., Jallu V., et al. Predictive value of sequential anti-HPA-1a antibody concentrations for the severity of fetal alloimmune thrombocytopenia. J Thromb Haemost 4 (2006) 628-637
22. Radder C.M., Brand A., and Kanhai H.H.H. Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it?. Vox Sang 84 (2003) 318-325
23. Overton T.G., Duncan K.R., Jolly M., Letsky E., and Fisk N.M. Serial aggressive platelet transfusion for fetal alloimmune thrombocytopenia: platelet dynamics and perinatal outcome. Am J Obstet Gynecol 186 (2002) 826-831
24. Birchall J.E., Murphy M.F., Kaplan C., and Kroll H. European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia. Br J Haematol 122 (2003) 275-288
25. Berkowitz R.L., Kolb E.A., McFarland J.G., et al. Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia. Obstet Gynecol 107 (2006) 91-96
26. Wenstrom K.D., Weiner C.P., and Williamson R.A. Antenatal treatment of fetal alloimmune thrombocytopenia. Obstet Gynecol 80 (1992) 433-435
27. Radder C.M., Brand A., and Kanhai H.H.H. A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia. Am J Obstet Gynecol 185 (2001) 683-688
28. Ni H., Chen P., Spring C.M., et al. A novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenous IgG therapy. Blood 107 (2006) 2976-2983
29. Radder C.M., de Haan M.J.J., Brand A., et al. Follow up of children after antenatal treatment for alloimmune thrombocytopenia. Early Hum Dev 80 (2004) 65-76
30. Ward M.J., Pauliny J., Lipper E.G., and Bussel J.B. Lonh-term effects of fetal and neonatal alloimmune thrombocytopenia and its antenatal treatment on the medical and developmental outcomes of affected children. Am J Perinatol 23 (2006) 487-492
31. Van den Akker E., Oepkes D., Lopriore E., et al. Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective. Br J Obstet Gynaecol 114 (2007) 469-473
32. Kroll H., Kiefel V., Giers O., et al. Maternal intravenous immunoglobulin treatment does not prevent intracranial haemorrhage in fetal alloimmune thrombocytopenia. Transfus Med 4 (1994) 293-296
33. Reznikoff-Etievant M.F. Management of alloimmune neonatal and antenatal thrombocytopenia. Vox Sang 55 (1988) 193-201
34. Van den Akker E., Oepkes D., Brand A., and Kanhai H.H. Vaginal delivery for fetuses at risk of alloimmune thrombocytopenia?. Br J Obstet Gynaecol 113 (2006) 781-783
35. Kwee A., Bots M.L., Visser G.H., and Bruinse H.W. Obstetric management and outcome of pregnancy in women with a history of caesarean section in the Netherlands. Eur J Obstet Gynecol Reprod Biol 132 (2000) 171-176
36. Greene M.F. Vaginal delivery after cesarean section-is the risk acceptable?. N Engl J Med 345 (2001) 54-55
37. Van den Akker E.S., De Haan T.R., Klumper F.J., et al. Severe fetal thrombocytopenia and hydrops in RhD alloimmunized pregnancies: independent risk factors. Am J Obstet Gynecol 197 (2007) S152
38. Saade G.R., Moise Jr. K.J., Copel J.A., Belfort M.A., and Carpenter Jr. R.J. Fetal platelet counts correlate with the severity of the anemia in red-cell alloimmunization. Obstet Gynecol 82 (1993) 987-991
39. de Haan T.R., van den Akker E.S., Porcelijn L., Oepkes D., Kroes A.C., and Walther F.J. Thrombocytopenia in hydropic fetuses with parvovirus B19 infection: incidence, treatment and correlation with fetal B19 viral load. Br J Obstet Gynaecol 115 (2008) 76-81